Ethylone
Ethylone is a synthetic entactogen and stimulant of the cathinone class.citation needed It is the β-keto analog of MDEA and emerged commercially around 2011 with minimal prior documentation of human use. Ethylone is commonly sold as a substitute or counterfeit for MDMA and methylone due to methylone's declining market availability. It is reported to be less potent than methylone, with effects that lean more toward classical stimulation than entactogenic warmth.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
The experience is that of a mild entactogen, broadly comparable to MDMA in character but consistently reported as subtler and less satisfying. Users frequently describe the effects as underwhelming relative to expectations, with the emotional warmth and euphoria of related empathogens present in a muted form. It is also reported to be less potent than its close relative methylone.
Physical
A mild stimulating effect accompanies the experience, consistent with its cathinone stimulant profile.
Cognitive
The headspace is a gentle, empathogenic one, with mild mood elevation and social warmth that fall noticeably short of the intensity associated with MDMA.
Emotional
Empathogenic effects are present but notably weaker than those of MDMA, often leaving users underwhelmed.
Pharmacology
Pharmacodynamics
Ethylone functions as a mixed monoamine reuptake inhibitor and releasing agent, acting on the serotonin, norepinephrine, and dopamine transporters.citation needed Relative to methylone, it displays approximately three-fold lower affinity for the serotonin transporter while maintaining similar affinity for the norepinephrine and dopamine transporters, resulting in a more balanced catecholaminergic-to-serotonergic activity profile. Although ethylone retains robust releasing capabilities, its overall pharmacological character has been described as more consistent with reuptake inhibition than with monoamine release.
Pharmacokinetics
Based on analysis of human and rat urine, ethylone undergoes metabolism via two primary pathways: N-deethylation to the corresponding primary amine and reduction of the beta-keto group to the respective alcohol.citation needed
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Dopaminergic stimulants
Harm Potential
Addiction & Dependence
Psychological
ModerateChronic use is regarded as moderately addictive, carries a high abuse potential, and can produce psychological dependence. If addiction develops, stopping suddenly may cause cravings.
Physical
LowWithdrawal effects may occur with sudden cessation of chronic use, though the nature and severity of physical withdrawal symptoms have not been well characterizedcitation needed due to limited research.
Psychosis Risk
As with other stimulants, abuse at high dosages for prolonged periods may result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Psychosis very rarely arises from occasional or moderate use.
Seizure Risk
Seizure risk from ethylone alone has not been documented in the available literature.
History & Culture
Ethylone is a synthetic cathinone that represents the β-keto analogue of MDEA, a substance colloquially known as "Eve."1 The compound has only a brief history of documented human use, with minimal records of consumption prior to its commercial emergence around…
Legality
International
Ethylone is not listed under the 1961 Single Convention on Narcotic Drugs. It is listed in a schedule of the 1971 Convention on Psychotropic Substances. It is not listed under the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
By Country
References
Source Pages
Citations
- 3,4-Methylenedioxyethcathinone (Ethylone) ["Bath salt," bk-MDEA, MDEC]. (2019). https://www.deadiversion.usdoj.gov/drug_chem_info/ethylone.pdf1
- Decreto N° 560/2019. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/decreto-560-2019-326675/texto1
- Decreto N° 560/2019. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/326675_dec560-1_pdf/archivo1
- Decreto N° 560/2019. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/ley-23737-138/actualizacion1
- Criminal Code Regulations 2019. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2019L00561/latest/text1
- Criminal Code Regulations 2019. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2025C01260/latest/text1
- Criminal Code Regulations 2019. legislation.gov.au (n.d.). https://www.legislation.gov.au/C2004A04868/latest/text1
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), Anlage II Z 4, read with § 4 Neue-Psychoaktive-Substanzen-Gesetz (NPSG). ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/eli/bgbl/ii/2011/468/ANL2/NOR402614411
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), Anlage II Z 4, read with § 4 Neue-Psychoaktive-Substanzen-Gesetz (NPSG). ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf1
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), Anlage II Z 4, read with § 4 Neue-Psychoaktive-Substanzen-Gesetz (NPSG). ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/eli/bgbl/i/2011/146/P4/NOR401344471
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Ethylone article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.